ABSTRACT
INTRODUCTION
The original concern over DNA hazards was raised in the mid-1950's when large amounts of viral vaccines were being produced. The major concern has been that the products may contain an oncogenic sequence. Multiple studies have been performed to determine the level of DNA in a product that can be considered safe (reviewed in Reference 1) . A level of 100 pg DNA per dose has been recommended by a World Health Organization (WHO) study (7) . The Federal Drug Administration (FDA) has stated that they will approach the need and level of acceptable DNA on a case-by-case basis (4) . Therefore, it is necessary to be able to measure DNA levels in the final bulk product and monitor its removal during the manufacturing process (2) . Recent discussions regarding "wellcharacterized proteins" will further magnify the importance of validating DNA removal methods during the purification process (3) .
Because DNA levels and matrix conditions vary during purification, DNA analysis in biopharmaceuticals can be very difficult. Current methods to quantitate DNA are based on absorbance, hybridization, protein binding methods and, to a limited extent, DNA amplification (5) . While each of these methods have specific applications, they are limited in their ability to quantitate DNA in various purification conditions.
There is a need for a simple, sensitive and rapid assay capable of measuring DNA under a wide range of conditions. The Total DNA Quantitation Assay handles a large number of samples in an accurate and cost-effective manner.
As the dye intercalates into the DNA, it emits fluorescence (530 nm) directly proportional to the amount of DNA present. This method was tested in the presence of several matrix components and proteins to determine their effect on the assay.
MATERIALS AND METHODS

Quantitation of DNA Using the Fluorescent Dye
DNA quantitation data were generated using the reagents and protocol contained in the Total DNA Quantitation Kit (PanVera, Madison, WI, USA), which contains Assay Buffer (50 mM Tris-HCl, pH 8.0), an intercalating fluorescent dye solution and a DNA Standard, φ X-174 RF I DNA, 20 ng/ µ L (6). Fluorescence measurements were performed using a Beacon ® Analyzer (PanVera) with 485-nm excitation and 530-nm emission interference filters. Fluorescence was reported in relative fluorescence units (rfu) and is dependent on the photomultiplier tube (PMT) voltage setting.
Nuclease Digestion Experiments
Bovine pancreatic DNase I (Sigma Chemical, St. Louis, MO, USA) and Phosphodiesterase I (PDE I) from Crotalus adamanteus (Pharmacia Biotech, Piscataway, NJ, USA) were re-hydrated according to the manufacturer's instructions. A DNase mixture containing 10 µ L of each enzyme was added to various amounts of DNA and protein in a final reaction volume of 100 µ L containing 100 mM Tris-HCl, pH 8.9, 100 mM NaCl, 14 mM MgCl 2 , and incubated at 37°C. Aliquots were analyzed for DNA concentration at various time points.
Specificity of the Fluorescent Dye for Various Nucleic Acids
φ X-174 RF I double-stranded (ds)DNA, M13mp18 singlestranded (ss)DNA and an RNA transcript were from PanVera. Lambda DNA was from Promega (Madison, WI, USA), Human and E. coli DNA were from Sigma Chemical. The synthetic oligonucleotides used were from Eppendorf (Milwaukee, WI, USA). Deoxynucleotides were from TaKaRa Shuzo (Otsu Shiga, Japan). One microgram φ X-174 DNA was digested with 20 U of Hae III (TaKaRa Shuzo and PanVera) in 50 µ L of buffer (20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM dithiothreitol [DTT], 10 mM MgCl 2 ). A second control reaction was prepared with 10 mM EDTA to inhibit digestion. The reactions were incubated at 37°C for 30 min, and then 10 mM EDTA were added to the first tube to stop digestion. The restriction fragments were analyzed to determine if reduction in size altered the assay intensity.
Sensitivity of the Assay to Potentially Inhibitory Substances
The Tris-HCl, MgCl 2 , NaCl and sodium dodecyl sulfate (SDS) were from PanVera. Nonidet ® P-40 (NP40) was from Pierce Chemical (Rockford, IL, USA). The urea and acetonitrile were from Fisher Scientific (Pittsburgh, PA, USA).
RESULTS
DNA Standard Curve Analysis
DNA quantitation was performed using two standard curves (Figure 1 ), each optimized for dye/DNA concentration. The high standard curve was linear from 3.13 to 200 ng DNA with a correlation coefficient ( r ) value of 1.0000 and a limit of quantitation (LOQ) of 0.033 ng DNA. The low standard curve was linear from 0.098 to 25 ng DNA with a typical r value of 1.0000 and an LOQ of 0.024 ng DNA. The LOQ was calculated by adding the mean intensity of the sample blank and 10 times the standard deviation of the sample blank. Similarly, the limit of detection (LOD) was calculated using the mean blank intensity plus three standard deviations.
Enzymatic Degradation of DNA Diminishes Fluorescence
DNA solutions (100 ng/mL) were monitored alone, in 100 µ g/mL bovine serum albumin (BSA) or 15 µ g/mL bovine gamma globulin (BGG), with and without the DNase mixture, at 10 min, 1 h, 4 h and 72 h. The fluorescence in the DNA solution was reduced 99% after nuclease treatment for 72 h ( Table 1 ). The fluorescence in the protein solutions decreased approximately 50% when treated with DNase. In a control experiment, ribonuclease A and ribonuclease T1 were shown to have no effect on fluorescence in DNA samples (data not shown).
Specificity of the Fluorescent Dye Assay for Various Nucleic Acids
A panel of nucleic acids was investigated to determine the specificity of the assay (summarized in Table 2 ). The RNA and DNA tested were of various sizes, ss or ds, circular, linear or superhelical, and from bacterial, viral or mammalian sources. The fluorescence in each nucleic acid solution was reported as a percent of the fluorescence in an equal concentration of the DNA Standard. The fluorescence of lambda phage, E. coli , human and a synthetic 25-bp oligonucleotide were 126%, 103%, 120% and 25%, respectively. The DNA Standard was digested with Hae III to produce 11 fragments with an average size of 490 bp. The fluorescence of the digested DNA was 97% of the undigested DNA Standard. ssDNA samples, including oligonucleotide homopolymers, were also tested for specificity in the assay. The fluorescence of the ss oligonucleotides ranged from 0.3%-19%, and an M13mp18 sample was 24% of the DNA Standard. A standard curve for ssDNA had a lower sensitivity with no loss in precision ( r= 0.9999; data not shown). The fluorescence of the RNA transcript (1800 base) and dNTPs were less than 1% and 0.1%, respectively.
Matrix Effects on Assay Sensitivity and Linearity
DNA standard curves were generated in the presence of several concentrations of NaCl, MgCl 2 , acetonitrile, urea, SDS, NP40, Tris-HCl and at several pHs. The slope of the DNA standard curves were compared to the slope for the control DNA standard curve and reported as a percent of the control slope. The r value (correlation coefficient) is reported to demonstrate that matrix components may reduce the sensitiv - 
DISCUSSION
We have developed a homogeneous fluorescence-based assay to monitor in-process DNA removal during recombinant protein manufacturing. The assay has two standard curves that augment the range, linearity and precision of the assay so that for DNA concentrations from 98 pg/mL to 200 ng/mL, the rvalue is 0.9999 and relative standard deviation is less than 2.0%.
The fluorescence was due to dye/DNA interactions and not because of dye/protein interactions. The dye was added to purified BSA or BGG spiked with standard DNA. DNase treatment of the DNA Standard reduced the fluorescence by greater than 95%, demonstrating that the observed fluorescence was dependent upon intact DNA. The specificity of the assay for various nucleic acids was determined. It is likely that during protein purification, DNA could be partially denatured and/or degraded. The DNA Standard in this assay is a well-characterized, supercoiled, dsDNA that is 44.8% GC. Long, dsDNA from a variety of sources and restriction digested DNA with an average fragment size of 490 bp produced the same fluorescence in the assay, while a short (25 bp) ds oligonucleotide generated only 25% the fluorescence of the DNA Standard. M13mp18, a long ssDNA The assay was tested with a panel of matrix components typically present in recombinant protein purification matrices. Adding matrix components decreased the sensitivity and range of the assay in a dose-dependent manner, with no change in linearity. DNA Standard curves can be developed in the presence of matrix components and used to quantitate DNA from protein samples. Alternatively, the effects that are because of salt can be eliminated through dilution or extraction of the DNA from the sample matrix. The dilution method is usually adequate for upstream samples where the DNA content is high relative to the protein of interest. Extraction is usually necessary when sensitivity requirements inhibit one's ability to dilute out the salt interference. This method has a detection limit of 1 ng/mL in a typical protein solution (i.e., BSA) at 1 mg/mL. This assay has been well-characterized for use in quantitating DNA under various matrix conditions and protein concentrations, which allows the assay to be used for method validation for DNA removal during recombinant protein manufacturing.
